Film and television drama writing assistant

Chapter 16 The Richest Man (6)
100 billion, 200 billion... 1000 billion...

In 2014, Meng Donglai surpassed Li Hejun to become the richest man in mainland China, and was called the dark horse among dark horses by netizens.

The Internet is full of stories about Meng Donglai's past, all kinds of gossip, nonsense, and speculation are full of netizens' eyes.

When reporters interviewed Meng Donglai about why he strongly supports serious illness charity, Meng Donglai said, "I'm not interested in money."

Remembering the interview with Meng Donglai on why his wealth has grown so fast, and why investing in the stock market can win the battle against ordinary people, Meng Dong said, "I set myself a small goal every day, and that is to earn [-] million."

....
Those quotations from "Versailles" in the previous life were shown over and over again by Meng Donglai.

However, he also knows to keep a low profile. Except for the occasional written interview with reporters, he never opens a meager self-media account such as Weibo, never organizes large-scale speeches or lectures, and invites to participate in government meetings can be pushed as he can.

Anyway, he is just an investor and not in charge of specific operations, so he doesn't have to worry about dealing with the local government.

2014/4/1

India's Supreme Court has dismissed a patent suit by Swiss drugmaker Novavax related to a cancer drug.

Nova sought the Indian court to affirm that the improved version of the anti-cancer drug "Glenin" developed by the company should be protected by patents, claiming that the improved version is easier for the human body to absorb, which is a major improvement.

However, the Supreme Court of India found that this improved drug "does not meet the two standards of innovation and originality", supporting the previous judgment of the Indian Patent Office.

In this world, many multinational pharmaceutical companies can apply to extend the patent protection period again by making slight modifications to the drug formulas they develop, and continue to make profits from "old drugs".

This approach is the "evergreen tree" that makes most pharmaceutical companies profitable.

The judgment of the Supreme Court of India this time means that such shameless tactics of pharmaceutical companies will not be applicable in India.

Those who support this judgment believe that this judgment protects the rights and interests of people in developing countries to obtain affordable medicines.

Opponents argued that the ruling "hinders innovation."

In any case, Meng Donglai finally no longer has to continue to buy back medicines from Indian pharmacies at high prices, nor does he need to supply them at home. This is great news for poor cancer patients and patients with rare chronic diseases in China.

Shanghai Junting, in Meng Donglai's mansion.

To celebrate this good news, Meng Donglai invited old friends from the beginning of his fortune to a dinner, including Cheng Yong.

"Old Lu, look at your big house, who would have thought that you couldn't even afford medicine ten years ago."

"Yes, the world is impermanent. At that time, who would have thought that I would have today." Meng Donglai invited everyone to sit down in the restaurant.

The five-meter-long oval solid wood dining table is big enough to seat a dozen people.

Peng Hao, Liu Sihui, Lao Liu, and some old guys who have been with Meng Dong from the beginning made the dining table full.

"I'm not as good as you in making money, but I'm definitely better than you in one thing." Cheng Yong was still a little stiff when he first came in, but after a few drinks, everyone let go.

"Tell me, how am I not as good as you."

"My son is doing his best. He was admitted to Fudan University this year."

"Hahahaha!" Meng Donglai laughed after hearing this.

In this life, Lu Yiyi's son had a good living environment since he was a child, and Wang Jia loved him too much, so he did have some deficiencies in education.

This is also because Meng Donglai has no experience in raising children, but he is sure that in reality, he will be able to educate his children well.

"You won. I'm not as good as you in this. Come, have a drink." The two smiled and clinked a glass.

"Brother Yong, Sister Sihui's child was admitted to Tsinghua University, and even skipped two grades in middle school." Peng Hao interjected, and directly stabbed Cheng Yong.

So many years have passed, although I still have some grievances about Cheng Yong's resignation from the group before, but I have already been able to treat it calmly.

But plainness is plainness, what should be hated or what should be hated

"You child..., if you want to say it, say it yourself, and use Sihui to say something." Of course, Cheng Yong couldn't give in.

"Look, my child will definitely do better than you in the exam, and I will send her to study abroad." After more than ten years of training, Peng Hao's eloquence has improved a lot.

When one person attains the Tao, the chicken and the dog ascend to heaven.

Living in a high position, his spirit is self-sufficient.

"It's fine to go abroad. I think the country is very good. Now the country is in chaos and it's not worth it." Meng Donglai retorted directly.

Calculating the time, if Peng Hao really wants to send his children abroad, it will happen just in time for the epidemic.

"That's right, it's good in China." Cheng Yong didn't expect Meng Donglai to speak for him, so he quickly picked it up.

"Brother Lu, I'm helping you..." Peng Hao rolled his eyes.

"Should I help you or not?" Meng Donglai laughed.

Old friends gathered together, and Meng Donglai's wealth had already reached the top, so there was no appeal among the people, and the atmosphere during the meeting was very harmonious.

"Speaking of foreign countries, you say that India is a really powerful country. It dares to stand up to the giants of international pharmaceutical companies." Someone said.

"Indeed, although it is a bit shameless, generic drugs have indeed benefited the people at the bottom a lot." Someone echoed.

"Speaking of generic drugs, I checked the information recently and found that this concept is not an invention of India, but the United States, which was the first to implement the patent strategy."

"Is there such a thing?"

Then someone started to spread it.

In 1984, the patents of about 150 commonly used drugs in the United States expired. According to the regulations at that time, if other manufacturers wanted to produce these drugs, they had to apply for new patents according to the new drug standards.

At this time, the "Harts-Workman Act (Drug Price Competition and Patent Term Compensation Act)" was born, and the production procedures of "generic drugs" were simplified. It has greatly benefited the well-being of the middle and lower classes of the society.

But now, India has become its biggest beneficiary.

"India's high court can make such a judgment because of its historical origin." Meng Donglai added: "In India, the mainstream view of society believes that in a well-ordered world, medical discoveries should be patent-free and should not be derived from human Between life and death for profiteering."

"Therefore, the first "Patent Law" after India's independence in 1970 stipulated that only process patents should be granted to food and drugs, and product patents should not be granted, directly abolishing the protection of drug patents."

This means that Indian pharmaceutical companies only need to slightly change some production processes to legally produce generic drugs.

At the same time, the "Drug Price Control Rules" promulgated by the Indian government also clearly stipulates that food and medicine consumption is an inalienable basic right of the poor, which eventually led to the main theme of low drug prices in India.

Even after India joined the WTO in 1995, the improvement of drug-related laws has been delayed again and again, and it still insists on its own national conditions in key parts.

"It's just that the national conditions are different. Whether it is good or bad, no one can say for sure." Meng Donglai finally concluded.

Lai Pi will naturally have the bitter fruit of being Lai Pi. Indian generic drugs are popular, and their own new drug research and development capabilities are naturally suppressed to a minimum.

Looking at the wave of epidemics in later generations, we know that in such a large country, the ability to develop vaccines by itself is almost the same, and even the raw materials for vaccine production have to be imported.

"Increased knowledge." Someone echoed.

This is Meng Donglai's mantra, which was learned by his subordinates.

"Okay, let's not talk about these serious topics. I called you here today because I have good news to share with you."

(End of this chapter)